Cited by 836Neuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and TreatmentsInflammasome and immune disorders

Microglia: Scapegoat, saboteur, or something else?

Open access
Aguzzi, Adriano, Barres, Ben A., Bennett, Mariko L.·2013·Science

Abstract

Microglia are resident immune cells in the brain and spinal cord. These cells provide immune surveillance and are mobilized in response to disparate diseases and injuries. Although microglial activation is often considered neurotoxic, microglia are essential defenders against many neurodegenerative diseases. It also seems increasingly likely that microglial dysfunction can underlie certain neurological diseases without an obvious immune component.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.1227901

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These controversial outcomes highlight a complex dual role of microglia, also observed in other brain diseases, and might be attributed to total removal of microglia being harmful, whereas targeting specific microglia activation states later in disease might prolong survival time.

    “These controversial outcomes highlight a complex dual role of microglia also observed in other brain diseases [54,55,56] and might be attributed to the fact that the total removal of microglia might be harmful, whereas targeting specific microglia activation states later in disease might prolong survival time.”

    From Loss of Homeostatic Microglia Signature in Prion Diseases (2022) · cites this paper as [54]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Aguzzi, A., Barres, B. A., & Bennett, M. L.
Affiliations
  • University Hospital Zurich (CH)
  • Stanford Medicine (US)
Corresponding author
  • Aguzzi, Adriano
  • Bennett, Mariko L.
Venue
Science
Published
2013-01-11
Volume
339
Issue
6116
Pages
156-161
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2044699444
Cited by
836
References
56
Citations by year
2026: 24 · 2025: 29 · 2024: 42 · 2023: 48 · 2022: 63 · 2021: 57 · 2020: 53 · 2019: 65 · 2018: 71 · 2017: 63 · 2016: 79 · 2015: 80 · 2014: 99 · 2013: 62
FWCI
10.18
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
National Institute of Neurological Disorders and Stroke (F31NS078813)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
microglia, neuroinflammation, neurodegenerative diseases, microglial activation, neuroprotection, immune surveillance, neurological disorders, microglial dysfunction
MeSH terms
Alzheimer Disease, Animals, Mental Disorders, Humans, Neuroimmunomodulation, Microglia, Neurodegenerative Diseases, Neurogenic Inflammation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review